Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
pirfenidone (esbriet) (1 trial)
Acute Kidney Injury (Phase 4)
Wounds and Injuries (Phase 4)
Trials (1 total)
Trial APIs (1 total)